AS

Alan F. Schatzberg

Stanford University: 7 patents #369 of 5,197Top 8%
CI Corcept Therapeutics Incorporated: 3 patents #24 of 80Top 30%
AN Akzo Nobel N.V.: 1 patents #670 of 1,625Top 45%
📍 Los Altos, CA: #908 of 3,651 inventorsTop 25%
🗺 California: #50,852 of 386,348 inventorsTop 15%
Overall (All Time): #418,919 of 4,157,543Top 15%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
9234242 Methods for treating depression using NCAM peptide mimetics Huda Akil, Stanley Watson, Cortney Turner, William E. Bunny, Edward G. Jones +1 more 2016-01-12
8415298 Administration of FGF2 for treamtent of anxiety Huda Akil, William Bunney, Prabhakara V. Choudary, Simon J. Evans, Edward G. Jones +10 more 2013-04-09
8178299 Method to determine the risk for side effects of an SSRI treatment in a person Greer M. Murphy 2012-05-15
7951538 Method to determine the risk for side effects of an SSRI treatment in a person Greer M. Murphy 2011-05-31
7326697 Methods for increasing the therapeutic response to electroconvulsive therapy Joseph K. Belanoff 2008-02-05
7083921 Method to determine the risk for side effects of an SSRI treatment in a person Greer M. Murphy 2006-08-01
6680310 Methods for preventing antipsychotic-induced weight gain Joseph K. Belanoff 2004-01-20
6620802 Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist Joseph K. Belanoff 2003-09-16
6399310 Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 Greer M. Murphy 2002-06-04
6369046 Methods for treating dementia Joseph K. Belanoff 2002-04-09
6362173 Methods for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists Joseph K. Belanoff 2002-03-26
6150349 Methods for treating psychosis associated with glucocorticoid related dysfunction Joseph K. Belanoff 2000-11-21